Dr. R. Roshan
Follow
  • Birthday February 3rd, 1974
  • Gender Male
  • Country India
  • Member WALS
    Yes
  • Phone Number
    98996577
  • Address
    Jhajhar Rajasthan
  • Brief CV
    Surgeon
  • Laparoscopic Sigmoidectomy for Cancer
    Laparoscopic sigmoidectomy with CME for cancer is becoming the gold-standard worldwide. The first step, after exposure, is the primary vascular approach. Personally, I always begin by the IMA dissection for controlling better the quality of the vascularization of the descending colon. I’m also proposing a customization of the splenic flexure mobilization. Lateral mobilization is enough in 80% of cases particularly in Asiatic patients with long compliant sigmoid loop. ICG vascular evaluation is not necessary if we respect basic tips and tricks I’m giving in this film. All my pupils adopted this surgical strategy with success. What do you think about?
  • Laparoscopy Hysterectomy Instrument
  • Dr TB Yuvaraja: With every robotic surgery the patient outcomes improve: Dr TB Y... (health.economictimes.indiatimes.com)
    In laparoscopic oncology procedure we saw the benefit to the patient which was huge in terms of less blood loss and less hospital stay.
  • LIVE SURGERY: Laparoscopic hemipelvectomy for huge deep endometriosis
    Presenting with unbearable left sciatic and pudendal pain
    due to huge nodule of deep endometriosis of the left parameter
    infiltrating the vagina, the bladder and the mid rectum.
    Left ureteral stenosis leading to severe hydronephrosis, left kidney atrophy and left nephrectomy 6 months before.
    Antecedents:
    - 2 laparoscopies for cystectomy of left ovarian endometriosis
    - total hysterectomy for pain
    - left nephrectomy for atrophy of the kidney

    Managed in live surgery for the 6th Workshop of Kochi, India
    Operative time: 2h
  • Minimally Invasive Surgery and Techniques International Congress - MISTIC 2016 (mistic2016.com)
    Regarding the progressive development of surgery and Minimally Invasive Surgery Techniques, which has replaced the traditional methods of open on surgeries one hand, and the progression of the prevalence of obesity and the need for the operation in morbid obese patients on the other hand, we are honored to invite you to the 12th international congress of Minimally Invasive Surgery and Techniques as a worthwhile opportunity for science and experience exchange among experts of various specialists.
    Attendance of internal medicine beside surgery and basic science has proposed a great opportunity for valuable innovation in medical industries in endoscopy and Minimally Invasive Surgery Techniques.
    Professors of various specialist from all over the world, Holding valuable education-practical workshops and great discounts for MIS equipment, make our congress distinct.
    We, therefore, are grateful to invite all professors, colleagues, residents, researchers and attendant to participate in our congress, to supply a splendid Scientifics environment for expanding science and treatment strategies.
    Special thanks
    Prof. Abdolreza Pazouki
    President of the Congress








    Dear Colleagues and Friends,
    It is an honor to invite you to the 12th World Congress of MISTIC which will take place in Tehran, Iran, from 9th through 11th of Nov. 2016.
    MISTIC was initially developed in 2011 as a vehicle to bring together the internationally recognized leaders in several disciplines of Minimally Invasive Surgery in a high quality, state-of-the-art, academic conference. It was conceived to fill a void in surgical education as currently there are few international meetings that bring the surgical world together in a concise, high level, interactive environment. The successful 2011 meeting was followed by subsequent conferences in 2011 and 2014. Several surgical subspecialties were represented and surgeons from around the world attended and participated as faculty or as audience. Additionally, residents and fellows were able to present their research.
    Today, MISTIC is a unique MIS surgical conference bringing some of the world’s most recognized surgeons together to share ideas, create academic relationships and advance the practice of surgery. Unprecedented in scope and depth, MISTIC 2016 is sure to be an excellent learning experience for all involved. Surgeons from all disciplines will find the content of the meeting to be meaningful. The talks, designed to be state of the art, provocative and educational, will be delivered by a prominent global faculty. Sessions will highlight popular surgical subjects such as General Surgery, GYN, Urology, ENT, Orthopedics, Neurosurgery, Interventional Radiology, Laser Medicine, Cardio Vascular surgery, Anesthesiology and their Subspecialties. There will also be emphasis on audience participation in a complex patient management cases session.
    It would seem only fitting that a conference of this quality should also be held in a truly spectacular venue. Tehran is a beautiful city with plenty to do and experience. Additionally, Tehran is a truly marvelous metropolis rich in history, spirituality and culture. It should be on anyone’s list of must-see countries.
    On behalf of the entire faculty, I welcome everyone to join MISTIC and participate in this truly wonderful experience.
    Farhadi M, MD
    Chief of the 12th International Congress of Minimally Invasive Surgeries and Techniques



    Dear Colleagues and friends,
    It is great pleasure to invite you to 12th International Congress of Minimally Invasive techniques & surgeries 9-11 November 2016.
    The aim of this congress is to offer a variety of topics covering the continuous developments in the field of Endoscopic surgery. This meeting will focus on Gastric, Colorectal, Biliary, Bariatric, Endocrine, Urological, ENT, Plastic and Gynecological Endoscopic updates.
    I hope this would also be a great opportunity for you to be able to spend some time visiting and enjoying many fascinating and historical sites in Iran such as Isfahan,shiraz and more.
    I am looking forward to seeing and welcoming you in Tehran.

    Professor H.Kalbasi, FRCS (ENg.), FACS.
    President of Association of Iranian Endoscopic Surgeons
    President, Iran Chapter American College of Surgeons



    Development of new methods in every field particularly in medicine, which is the result of hardworking human endeavor in the world, initially, faces with some resistance of technicians in comparison with previous traditional methods. But these resistances decline as we go forward. Endoscopic surgery also was faced with resistance and severe criticism in Iran, initially. But now it has become an accepted and routine method. On the other hand, due to the application of this technique in different surgical groups, almost it's going to be pandemic. So, the formation of procedures which work with endoscopic method is a necessary point that is being shaped by accepting this principle by all stakeholders, fortunately. Due to this principle, the country's laparoscopic association believes that it's necessary to have all of surgery fields and is inviting different surgery groups to participate and share their ideas since two years ago which is a good event. We hope that the Endoscopic Surgery Association can perform correct scientific and practical plans with paying attention to country's native situation and with cooperation and efforts of all surgical groups.
    Dr. Javad Bastar
    The chief of thorax surgery association




    In the name of God
    An explorer human, searches for science anywhere and anytime, by comparison and conclusions, and finds eternal truth called "vital energy" in everything that exists in different shapes but undying.
    Human knows that for any mental or physical movement and thus continue living, is faced with sensitive situation and if the balance is saved and the exchange with energy is done in a basic correct way, he/she is healthy both mentally and physically and spends natural process of his/her life.
    From the perspective of acupuncture, chaos and disorganization due to lack or excess of total and partial energy in every period of life do not have anything except illness.
    This medicine with more than its three thousand year old history, is an important branch of traditional Chinese medicine that is identified as an effective way for diagnosis, prevention, treatment and rehabilitation of some diseases during the 70s decade by WHO.
    The Iranian Scientific Acupuncture Association, hopes healthiness and success for all partners and hopes to do some effective work for decreasing pain of patients by having two views of classic medicine and acupuncture and aligning these two theories together and improving the quality and quantity of acupuncture.
    Dr. Reza Heshmat
    The chief of Iranian Scientific Acupuncture Association



    Dear Friends and Colleagues
    On behalf of the congress Organizing Committee of MISTIC 2016, I bid you welcome to attend the 2016 MISTIC Meeting in Tehran, Iran. Iranian laparoscopic surgeons are well known all over world for their skill and they have a strong tradition of caring for their nation as well as being a leading centre for training and research.
    The theme for this Congress is focused on all the recent advancements of Minimally Invasive Techniques. The meeting will hold on Razi International Conference Center and emphasises the importance of how we need to prepare our surgeons in how they would provide care to our people in the coming years with advancements in technology and innovation, minimal access surgical techniques and changes in the socioeconomic and healthcare demands of our nations.
    This Congress also sees a novel approach as the Organising Committee under the supervision of DR. H. Kalbasi, president of Iranian chapter of ACS, and WALS and Dr. Abdolreza Pazouki, Director of MIS Research Center has planned the Congress around hands-on, interactive workshops so that there is seamless and integrated engagement of participants across the various topical tracks. This is possible because the Congress will be held in the supervision of many other pioneer of laparoscopic surgery in Iran. There is dedicated state-of-the-art skills training and education space in university which will serve the needs for the concurrent Congress symposia and workshops.
    Teharan will be an even more exciting place in 2016 with new tourist attractions opening, and I am looking forward to welcoming you here at the 12th International Congress of Minimally Invasive Surgery Congress MISTIC 2016.

    Dr. R.K. Mishra. MBBS, MS, MRCS, Dip. LAP, FICRS, FIMSA
    Chairman World Laparoscopy Hospital, Gurgaon, India
    Professor and Head of Minimal Access Surgery, TGO University, India
    First University Qualified Master Minimal Access Surgeon of India (M.MAS)
    Editor in Chief World Journal of Laparoscopic Surgery (WJOLS)
    General Secretary World Association of Laparoscopic Surgeon (WALS)
    General Secretary International College of Robotic Surgeons (ICRS)
    Member European Association for Endoscopic Surgery (EAES)
    Member European Association for Transluminal Surgery (EATS)
    Member Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
    Member Society of Laparoendoscopic Surgeons (SLS)
    Member Society of Robotic Surgery (SRS)
    Member Clinical Robotic Surgery Association (CRSA)
    Fellow of International Medical Sciences Academy (IMSA)
    Member Indian Association of Gastrointestinal Endosurgeons (IAGES)
    Member Association of Surgeons of India (ASI)
    Member Indian Medical Association (IMA)
  • FDA Approves New Power Morcellation Device
    Home Page >> News Articles >> FDA Approves New Power Morcellation Device

    FDA Approves New Power Morcellation Device
    May 8, 2016, 08:00:00AM. By Heidi Turner
    Washington, DCThe US Food and Drug Administration (FDA) has approved a new containment device for use with certain laparoscopic power morcellation devices. The system is designed to isolate uterine tissue that is not believed to be cancerous. The device approval comes amid lawsuits alleging women were put at risk of serious cancer complications caused by laparoscopic uterine surgery using power morcellation.

    FDA Approves New Power Morcellation DeviceIn a news release issued April 7, 2016, the FDA notes that it has approved the use of the PneumoLiner, designed to effectively contain uterine tissue. Despite the approval, the FDA also said the maker of the PneumoLiner must warn patients and health care professionals that the system has not been proven to reduce the risk of spreading cancer.

    According to an analysis, the FDA estimates that one in 350 women who undergo hysterectomy or myomectomy for non-cancerous growths actually has an unsuspected uterine sarcoma. During laparoscopic uterine surgery, power morcellation breaks up the uterine tissue into small pieces so they can be removed through a tiny incision. Women who have an unsuspected uterine sarcoma are put at risk that breaking up the tissue will result in cancerous tissue being spread throughout their abdomen, increasing the risk of death.

    Although the PneumoLiner is designed to contain tissue created by breaking up the fibroids, it has not yet been proven to reduce the spread of potentially cancerous tissue. As a result, the FDA is still not recommending laparoscopic uterine surgery using power morcellation for the majority of women who require removal of fibroids.

    “This new device does not change our position on the risks associated with power morcellation,” said William Maisel, MD, MPH, deputy director for science and chief scientist at the FDA’s Center for Devices and Radiological Health.

    Lawsuits have been filed by women alleging the use of power morcellation during their laparoscopic uterine surgery resulted in the spread of cancerous tissue. As of April 15, 2016, 30 lawsuits were consolidated for pretrial proceedings in MDL 2625. The situation is concerning enough that in 2015, members of Congress asked the US Government Accountability Office to examine how it was possible for power morcellators to stay on the market, despite there being evidence of a risk of spreading undetected cancer.
  • Olympus Unveils Big Screen Surgery In 4K
    Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, today unveiled VISERA 4K UHD System, its state-of-the art Big Screen surgical system, at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2016 Annual meeting in Boston.

    The VISERA 4K UHD System delivers four times the resolution of HD with better light and wider color spectrum, promising to help surgeons operate with increased precision and confidence. The only fully integrated 4K imaging chain available for healthcare use, VISERA 4K UHD allows operating room (OR) personnel to get closer to the operating field as they view cases live on a 55-inch operative display that magnifies anatomical features to deliver more visual information to the entire surgical team.

    Olympus' VISERA 55-inch primary operative display transforms minimally invasive surgery into an immersive experience by bringing the entire surgical team into the operation.



    Olympus' VISERA 55-inch primary operative display transforms minimally invasive surgery into an immersive experience by bringing the entire...
    While bringing more efficiency to the hospital, it has also been shown that minimally invasive surgery can provide significant improvements in morbidity and mortality over open surgery, with benefits to patients including less post-operative pain and faster recuperation.

    VISERA 4K UHD, the first of many products from the Sony Olympus Medical Solutions joint-venture, is now transforming healthcare by enhancing minimally-invasive surgery in a range of surgical specialties including general surgery, gastroenterology, gynecology, thoracic and urology for an estimated 20 million procedures annually. Olympus' first customers began using VISERA 4K UHD during the first week of March 2016.

    "The color and contrast in the Olympus 4K image provides superb clarity, unlike any operative video image I have seen before," said Dr. Ninh Nguyen, Professor and Interim Chair, Department of Surgery at the University of California Irvine Medical Center.i "The image is so clear that I was able to see down to the capillary level. [Seeing the capillary level] is important for improved dissection of tissue and evaluating the perfusion of the tissue."

    Benefits of the Integrated VISERA 4K UHD System:

    The VISERA 4K UHD System was created to address unmet needs in surgical imaging by improving the visual elements essential for laparoscopic and arthroscopic surgery – light, color and resolution – via an optimized 4K imaging chain that works seamlessly together to improve visibility.

    Light
    To improve visibility, the VISERA 4K UHD System provides additional light to illuminate bleeding in surgical fields, visualize deep surgical cavities and enhance the viewing experience of a 5 mm telescope.

    VISERA 4K UHD's advantages include:

    Enabling advanced multi-quadrant procedures (5 mm)
    Enhancing procedures with challenging access (5 mm)
    Structure enhancement allows clearer recognition of human tissue
    Providing compatibility with narrow band imaging
    Color
    Current surgical imaging technology offers only limited intra-operative color enhancement for identifying anatomical structures and for precise tissue delineation.

    VISERA 4K UHD's advantages include:

    Reproducing more vivid shades of red and yellow for better visualization
    Allowing surgeons to observe fine patterns and structures in high precision
    Delivering higher contrast levels with more detailed visualization to support greater accuracy
    Higher Resolution
    Current surgical imaging platforms do not allow for the level of magnification that can be experienced with Olympus 4K imaging.

    The VISERA 4K UHD System:

    Creates high-resolution images to help physicians identify fine patterns and anatomical structures
    Creates an immersive experience through a reduced viewing distance and large format primary operative display
    "With the introduction of the VISERA 4K UHD System, we launch a new chapter in the evolution of minimally invasive surgery – the era of Big Screen Surgery," said Todd Usen, President, Olympus Medical Systems Group at Olympus Corporation of the Americas. "Olympus is committed to ensuring that as the tools and techniques for minimally-invasive surgery evolve, we achieve commensurate progress in creating imaging solutions that approximate the direct view of open surgery. By working closely with OR teams around the world, and our partner Sony who brings the most advanced electronics, Olympus is proud to provide our US customers with the VISERA 4K UHD system for the ultimate visibility and clarity during surgery."

    Each component of the VISERA 4K UHD System is built specifically for it by Sony Olympus Medical Solutions to ensure highest quality, control and cohesiveness of the unit. For more detailed information and full list of the VISERA 4K UHD System please visit medical.olympusamerica.com/products/VISERA-4K-UHD-System.

    About Sony Olympus Medical Solutions
    As a supplier of a complete range of endoscopes, Olympus has long been engaged in the development, manufacture and sales of endoscopy products for surgical use. Sony has a long history of state-of-the-art digital imaging offerings. In 2013 the joint venture Sony Olympus Medical Solutions was formed with the aim of contributing to advances in the medical field by developing improved endoscope systems that draw on Sony's state-of-the-art digital imaging technologies and know-how, especially for 4K imaging, as well as Olympus' lenses and other optical technologies and its experience in medical equipment manufacture and development.

    About Olympus Medical Systems Group
    Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.
  • Abdominal hernia repair recovery takes longer than expected, especially in women
    Abdominal hernia repair recovery has been found to take longer than expected, especially in women. The findings from the Mayo Clinic suggest that patients should be able to quickly return to their normal activities following an abdominal hernia repair, but many patients still experience pain and fatigue up to several days after the surgery. Furthermore, individuals under the age of 60 and women were found to have longer recoveries.

    Senior author Juliane Bingener-Casey said, “Physicians may need to work with patients to set more realistic expectations about recovery and help them better cope with pain and fatigue after the procedure. It may be that people expect, when they’ve seen their neighbors after laparoscopic gall bladder surgery and they’re back taking a walk the next day that they’ll be able to do the same thing with laparoscopic ventral hernia repair. They will probably find out that it takes several days before they start moving the way they usually do.”

    Laparoscopic ventral hernia repair is performed when a gap forms in-between the muscles in the abdomen. It is the most common form of surgery for an abdominal surgery with 90,000 ventral hernia repairs occurring annually in the U.S. alone.

    The researchers looked at 18 patients up to one week after their surgery, which is considered the worst part of the recovery. Dr. Bingener-Casey explained, “It’s worse than expected for the patients probably. So I think it’s important for patients to have a realistic expectation, so they’re not surprised and disappointed. For the surgeons, it’s important to look at what we can do to improve recovery. Is it the pain control, is there other help we can provide to get through the pain or through the fatigue for the time after surgery?”
  • Bariatric Surgery: Kidney Stone Risk?
    A team of researchers from the Mayo Clinic published a meta-analysis assessing the risk of kidney stones following bariatric surgery in the latest issue of Renal Failure. They looked for studies that followed patients for two to four years after surgery.

    The researchers found only four studies that met their strict inclusion criteria. One was a randomized controlled trial and the others were cohort studies. Among the studies, they were able to include 11,348 patients.

    They determined that the pooled relative risk for kidney stones in patients undergoing bariatric surgery was 1.22.

    Patients who had undergone Roux-en-Y gastric bypass were at higher risk than others, with a pooled relative risk of 1.73 compared to a control group that did not have surgery.

    Restrictive procedures (ie. laparoscopic banding or sleeve gastrectomy), which are not as effective as Roux-en-Y procedures but seem to cause no hyperoxaluria, were associated with a lower risk of kidney stones (RR of 0.37).

    Obesity itself raises risk of kidney stones by increasing urinary calcium and oxalate excretions, predisposing patients to calcium oxalate crystallization. Obesity-related insulin resistance acidifies urine, also creating an environment ripe for stones. Studies have shown that patients who undergo bariatric surgery often continue to have significant hyperoxaluria, especially in the six months following surgery.

    The researchers indicate that bariatric procedures can cause fat malabsorption, which can lead to enteric hyperoxaluria and calcium oxalate stone formation. These findings are limited by the small number of studies and inclusion of only one randomized controlled study.
  • Please click here to download Informed consent and request for laparoscopy
    Prior to performing a new laparoscopic surgery procedure, appropriate training is necessary. Document the indications in support of the performance of the laparoscopic procedure when evaluating patients for surgery. If contraindications are present, document specific reasons why the benefits of surgery outweigh the risks.

    Please download from here Informed consent and request for laparoscopy
  • Totally Laparoscopic Whipple for Pancreatic Cancer
    Totally Laparoscopic Whipple for Pancreatic Cancer with "The first artery approach" anda a safe Dunking pancreaticojejunostomy
  • Titan Medical Inc. is a Canadian public company focused on the design and develo...
    Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's Single Port Orifice Robotic Technology, SPORT™ Surgical System, currently under development, is comprised of a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT™ Surgical System is being designed to expand robotic surgery into both simple and complex areas of surgical specialties and procedures that are currently under-serviced. It is also being designed to allow surgeons to perform procedures within small- to medium-size surgical spaces for general abdominal, gynecologic, and urologic indications. For more information, visit the Company's website.